Table 4.
Category | Lack of scientific evidence | Suspicious of KM safety | Unstandardized clinical protocol | Low efficacy | Unfamiliarity of KM therapies | Irrational KM doctors’ explanations | Discomfort with practice | Others | P-value |
---|---|---|---|---|---|---|---|---|---|
(Average) | (52.2) | (35.7) | (35.5) | (25.9) | (15.8) | (7.9) | (6.4) | (5.2) | <0.001 |
Gender | |||||||||
Male | 59.3 | 25.2 | 36.4 | 25.2 | 19.2 | 7.9 | 7.5 | 5.6 | |
Female | 44.3 | 47.4 | 34.4 | 26.6 | 12.0 | 7.8 | 5.2 | 4.6 | |
Age (yr) | 0.047 | ||||||||
20–29 | 49.4 | 19.1 | 43.8 | 20.2 | 20.2 | 10.1 | 7.9 | 7.7 | |
30–39 | 57.4 | 23.1 | 37.0 | 31.5 | 13.0 | 9.3 | 6.5 | 5.6 | |
40–49 | 52.7 | 41.9 | 32.3 | 26.9 | 18.3 | 5.4 | 7.5 | 2.2 | |
50–59 | 54.2 | 55.6 | 30.6 | 25.0 | 6.9 | 9.7 | 4.2 | 1.4 | |
60–69 | 40.9 | 54.5 | 29.5 | 22.7 | 22.7 | 2.3 | 4.5 | 6.8 |
The 406 respondents who cited KM distrust were surveyed. The questions allowed for multiple answers. The values represent percentages of participants